SEC Comment Letter for Vincerx Pharma, Inc. (VINC) (CIK 0001796129) (VINC) — Mar 4, 2020
Vincerx Pharma, Inc. (VINC) (CIK 0001796129)
Date: March 4, 2020 · CIK: 0001796129 · Accession: 0000000000-20-001967
AI Filing Summary & Sentiment
File numbers found in text: 333-236466
Letter
March 4, 2020 Andrew McDonald Chief Executive Officer LifeSci Acquisition Corp. 250 W 55th Street, #3401 New York, NY 10019 Re:LifeSci Acquisition Corp. Amendment No. 2 to Registration Statement on Form S-1 Filed March 3, 2020 File No. 333-236466 Dear Mr. McDonald: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Form S-1/A Exhibits 1.Please reconcile the exclusive forum provision in exhibit 3.2 with your disclosure on page 81 or advise.
FirstName LastNameAndrew McDonald Comapany NameLifeSci Acquisition Corp. March 4, 2020 Page 2 FirstName LastName Andrew McDonald LifeSci Acquisition Corp. March 4, 2020 Page 2 You may contact Jeffrey Lewis at 202-551-6216 or Kristina Marrone at 202-551-3429 if you have questions regarding comments on the financial statements and related matters. Please contact Ronald (Ron) Alper at 202-551-3329 or Brigitte Lippmann at 202-551-3713 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction cc: Giovanni Caruso
Show Raw Text
March 4, 2020
Andrew McDonald
Chief Executive Officer
LifeSci Acquisition Corp.
250 W 55th Street, #3401
New York, NY 10019
Re:LifeSci Acquisition Corp.
Amendment No. 2 to Registration Statement on Form S-1
Filed March 3, 2020
File No. 333-236466
Dear Mr. McDonald:
We have reviewed your amended registration statement and have the following
comment. In our comment, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to this comment, we may have additional comments.
Form S-1/A
Exhibits
1.Please reconcile the exclusive forum provision in exhibit 3.2 with your disclosure on page
81 or advise.
FirstName LastNameAndrew McDonald
Comapany NameLifeSci Acquisition Corp.
March 4, 2020 Page 2
FirstName LastName
Andrew McDonald
LifeSci Acquisition Corp.
March 4, 2020
Page 2
You may contact Jeffrey Lewis at 202-551-6216 or Kristina Marrone at 202-551-3429 if
you have questions regarding comments on the financial statements and related matters. Please
contact Ronald (Ron) Alper at 202-551-3329 or Brigitte Lippmann at 202-551-3713 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc: Giovanni Caruso